MMP2 and neoplasm: Since MMP-2 was enriched in TME (Figure S25), MMP-2 linker could be cleaved within the tumor microenvironment, and the free D-type anti-PD-L1 peptide can bind to the PD-L1 receptor on tumor cells to block the potential impact of tumor cell immune escape.